San Antonio, Texas, Jan. 26, 2018 -- South Texas Blood & Tissue Center, a subsidiary of BioBridge Global, today launched a program to aid accident and trauma patients served by area air medical services and hospital helicopters. The program, “Brothers in Arms,” will enable air medical crews to administer special pre-hospital transfusions of whole blood, proven to counter blood loss and dramatically improve survival rates when tested in battlefield situations.
|
|||||||||||||
San Antonio is one of the first cities to implement the system, which is based on a battlefield transfusion program developed by the U.S. military and later adapted at the Mayo Clinic trauma center. The 75th Ranger Regiment “O Low-Titer Whole Blood Program” was the recipient of the Army’s Greatest Innovation Award in 2017
Research led by Dr. Donald Jenkins, a former U.S. Air Force officer and the principal architect of the Joint Trauma Theater Trauma System in Iraq and Afghanistan, showed that combining the practice of pre-hospital transfusions with specially tested units of whole blood – rather than transfusing individual blood components of red cells, plasma or platelets – is most effective in treating trauma victim suffering from significant blood loss.
“The general mortality rate for critically injured patients requiring massive transfusions at hospital trauma centers is 75 percent,” said Jenkins. “Our battlefield experience showed that providing earlier, pre-hospital transfusions of whole blood, rather than blood components or primarily red blood cells, brought mortality rates down as low as 20 percent.”
Dr. Jenkins later began to transfer the program to civilian use as trauma medical director at the Mayo Clinic. He is now a surgical critical care specialist affiliated with University Hospital in San Antonio, and the Betty and Bob Kelso Distinguished Chair in Burn and Trauma Surgery at UT Health San Antonio.
“Implementing this program for civilian use will truly transform how emergency care can be administered on medical helicopters and significantly improve survival rates for trauma victims.” said Elizabeth Waltman, COO of the South Texas Blood & Tissue Center. “This is also the first step towards a longer-term solution for saving more lives in mass-casualty situations, especially if we are able to expand the program in the future to include emergency care provided by ambulance services.”
The new program represents a collaboration involving the South Texas Blood & Tissue Center, the Southwest Texas Regional Advisory Council (STRAC), University Health System, the San Antonio Military Medical Center, The US Army Institute of Surgical Research, the UT Health Science Center and medical helicopter services Air Evac Lifeteam, PHI Inc. and San Antonio AirLIFE.
The program was established in San Antonio with support from a grant provided by the San Antonio Medical Foundation.
Blood for the Brothers in Arms program will come from the South Texas Blood & Tissue Center, donated by specially tested male O-positive donors.
The universal blood type generally used for emergency transfusions, O-negative, is found in just 7 percent of the population. More than 30 percent of donors are type O-positive, making it the most common blood type. South Texas Blood & Tissue Center’s sister blood-testing organization, QualTex Laboratories, worked with the military to develop the testing protocol to identify O-positive donors with low antibody levels, making it possible to use O-positive blood for these trauma victims. The program is targeting male O-positive donors because men tend to have lower levels of certain types of antibodies in their blood than women, reducing the possibility of adverse reactions in patients.
STBTC is working to sign up a committed pool of male O-positive donors for the Brothers in Arms program to ensure a regular supply of specially tested whole blood for medical helicopters. The goal is to eventually expand the program to provide whole blood to area emergency vehicles.
Male donors who would like to see if they qualify to be a “Brothers in Arms” volunteer are encouraged to call 210-731-5590 to schedule an appointment for testing.
###
About the South Texas Blood & Tissue Center: The South Texas Blood & Tissue Center (STBTC) is a nonprofit community blood center that provides blood, plasma, platelets and other blood components to more than 70 hospitals in 43 South Texas counties. It is the largest blood supplier in our region. STBTC has a proud 42-year history serving the South Texas community. The center is a subsidiary of BioBridge Global, a nonprofit organization comprising services for regenerative medicine and research including blood banking and resource management; cellular therapy; umbilical cord blood collection and storage; donated human tissue recovery and distribution for transplant; and testing of blood and plasma products to help patients in South Texas, the United States and worldwide. STBTC has seven donor rooms in South Texas and conducts thousands of mobile blood drives each year. Visit us at SouthTexasBlood.org and BioBridgeGlobal.org.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/883961db-e22f-4e83-9988-776c5cac8542
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a53bee65-bcfe-4b6b-bd53-3ee060963023
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/da72805f-6352-4a05-8fd6-c4bed9270e06
Monica Reyes BioBridge Global 210-612-8879 [email protected] Roger Ruiz South Texas Blood & Tissue Center 210-296-9026 [email protected]


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Instagram Outage Disrupts Thousands of U.S. Users
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



